List view / Grid view
Genzyme is developing LEMTRADA in MS in collaboration with Bayer…
12 June 2012 | By Sanofi
Genzyme is developing LEMTRADA in MS in collaboration with Bayer HealthCare...
Full CARE-MS II results for Alemtuzumab to be unveiled...
20 April 2012 | By Sanofi
Full CARE-MS II results for Alemtuzumab to be unveiled...
Genzyme has begun shipping Fabrazyme® (agalsidase beta)...
1 March 2012 | By Sanofi
Genzyme has begun shipping Fabrazyme® (agalsidase beta)...
The FDA has approved its manufacturing plant in Framingham, Mass.,…
24 January 2012 | By Sanofi
The FDA has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme® (agalsidase beta)...
Sanofi & Genzyme announced that the EMA has approved its…
18 January 2012 | By Sanofi
Sanofi & Genzyme announced that the EMA has approved its manufacturing plant in Framingham....
The Phase lll CARE-MS ll trial met both of its…
14 November 2011 | By Sanofi
The Phase lll CARE-MS ll trial met both of its co-primary endpoints...
Sanofi announced the appointment of David Meeker as Chief Executive…
24 October 2011 | By Sanofi
Sanofi announced the appointment of David Meeker as Chief Executive Officer of Genzyme, effective November 1, 2011...
New results from the CARE-MS I trial...
22 October 2011 | By Sanofi
New results from the CARE-MS I trial...
